| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/06/2000 | US6072105 Includes bacillus thuringiensis cryiiia gene which produces insecticidal protein making plant resistant to colorado potato beetle |
| 06/06/2000 | US6072103 Dna construct for inducible gene expression includes a transcriptional initiation region from a pathogen inducible-rapid response grape stilbene synthase gene; for transgenic plants |
| 06/06/2000 | US6072102 Reversible nuclear genetic system for male sterility in transgenic plants |
| 06/06/2000 | US6072050 Synthetic promoters |
| 06/06/2000 | US6072049 Hepatitis B surface antigen vaccine |
| 06/06/2000 | US6072047 Nucleotide and amino acid sequence that binds the protein known as tumor necrosis factor-related apoptosis-inducing ligand; for recombinant expression; for purifying protein or suppressing activities |
| 06/06/2000 | US6072045 Chimeric isoprenoid synthases and uses thereof |
| 06/06/2000 | US6072044 Polynucleic acid structures with at least one triangular unit; have structural rigidity necessary to serve as building block components for two and three dimensional structures |
| 06/06/2000 | US6072043 Optimally fluorescent oligonucleotides |
| 06/06/2000 | US6072041 Single chain fv molecule directed against a transcytotic receptor covalently linked to a therapeutic protein; to deliver therapy to the other side of a cell |
| 06/06/2000 | US6072039 Hybrid polypeptide comparing a biotinylated avidin binding polypeptide fused to a polypeptide of interest |
| 06/06/2000 | US6072037 Antibodies to the IL-17 receptor |
| 06/06/2000 | US6072036 Antibody containing a secretory signal and an intracellular retention sequence; for genetically engineered expression inside cells; for antitumor/anticarcinogenic agents and viricides |
| 06/06/2000 | US6072033 Receptor that binds IL-17 |
| 06/06/2000 | US6072032 Amino acid sequence of polypeptide involved in protein secretory apparatus of bacteria; for screening for bactericides and bacteriostats; diagnosis of and prophylaxis for infections |
| 06/06/2000 | US6072029 Derivatives of human α1 -antitrypsin and process for their preparation |
| 06/06/2000 | US6072028 Amino acid sequence of effector cell protease receptor-1, a transmembrane glycoprotein receptor for factor xa; immunosuppressants for autoimmune disorders; suppression or activation of lymphocyte proliferation; diagnosis of disease |
| 06/06/2000 | US6071894 Sensor histidine kinase of Staphylococcus aureus |
| 06/06/2000 | US6071892 Polynucleotides that encode the polypeptide of tyrosyl synthetase have amino acid homology to a known bacillus subtilis tyrosyl trna synthetase protein |
| 06/06/2000 | US6071891 Insulin-like growth factor 1 receptors (IGF-1R) antisense oligonucleotide cells composition |
| 06/06/2000 | US6071890 Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
| 06/06/2000 | US6071889 In vivo genetic modification of growth factor-responsive neural precursor cells |
| 06/06/2000 | US6071878 Bacillus thuringiensis israelensis polypeptides that is toxic to mosquito larvae comprising a 135 kd polypeptide, a 125 kd polypeptide, and a 68 kd polypeptide but devoid of the 28 kd polypeptide having hemolytic activity |
| 06/06/2000 | US6071877 Polypeptides having a toxic activity against insects of the dipterae family |
| 06/06/2000 | US6071747 Human preadipocytes for developing antiobesity and antidiabetic agents; cells include immortalizing fragment of viral oncogene, promoter from viral oncogene or human vimentin gene, and express certain proteins |
| 06/06/2000 | US6071745 Contacting eukaryotic cells with isotonic, nuclease-free aqueous solution which has been pretreated with diethyl pyrocarbonate, lyophilizing cells, maintaining under sealed conditions |
| 06/06/2000 | US6071743 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 06/06/2000 | US6071742 Coxsackie virus as a vector for delivery of anti-inflammatory cytokines |
| 06/06/2000 | US6071737 Equine Neospora isolate and its uses |
| 06/06/2000 | US6071736 Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus |
| 06/06/2000 | US6071735 Enzyme preparation with endoglucanase activity |
| 06/06/2000 | US6071734 Ribonuclease h from human hepatitis b virus; for recombinant production and identifying enzyme inhibitors |
| 06/06/2000 | US6071733 Method of making recombinant enzyme |
| 06/06/2000 | US6071731 Enzymatic polypeptide for the attachment of histidine to transfer ribonucleic acid molecule; bactericides; wound healing agents |
| 06/06/2000 | US6071730 Cell ablation using trans-splicing ribozymes |
| 06/06/2000 | US6071729 Disruption of the cytochrome C gene in xylose-fermenting yeast |
| 06/06/2000 | US6071725 Vectors expressing ice nucleation protein fusions for cell surface anchoring of foreign proteins |
| 06/06/2000 | US6071724 Streptococcus pneumoniaegene sequence era |
| 06/06/2000 | US6071723 Inhibitors of human plasmin derived from the Kunitz domains |
| 06/06/2000 | US6071722 Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1) |
| 06/06/2000 | US6071721 Calcium binding protein |
| 06/06/2000 | US6071720 Polynucleotide coding a polypeptide associated with ionic mobility; for the diagnosis, treatment or prevention of nervous system disorders, cardiovascular disorders and cancer; anticarcinogenic agents |
| 06/06/2000 | US6071719 Polynucleotide sequence coding a membrane protein; for the treatment and prevention of infections |
| 06/06/2000 | US6071718 Synthesizing caseins in vivo; constructing expression vector which codes caseins and a peptidase, transforming cells, allowing cleavage of casein product |
| 06/06/2000 | US6071716 Nucleotide sequence coding for a lymphocyte activation antigen protein associated with immune response |
| 06/06/2000 | US6071715 Nucleic acids encoding novel proteins which bind to retinoblastoma protein |
| 06/06/2000 | US6071713 Bioprocesses for preparing 7-ACA and 7-ADAC |
| 06/06/2000 | US6071705 Method of detecting neurological disease or dysfunction |
| 06/06/2000 | US6071701 Detecting polynucleotide sequences which code polypeptide associated with inflammation; contacting nucleic acids with a polynucleotide sequence which codes inflammation polypeptide, allowing hybridization, detecting hybridization products |
| 06/06/2000 | US6071700 Screening for modulators of the degradation of nucleotide sequences; obtaining cell expressing wildtype and mutant genes, incubate with modulator, monitor gene expression of transcripts, altered expression indicates modulating activity |
| 06/06/2000 | US6071698 DNA extraction buffer and method of use thereof |
| 06/06/2000 | US6071697 Method for testing the differentiation status in pancreatic cells of a mammal |
| 06/06/2000 | US6071696 Method of producing a temporally spaced subtracted (TSS) CDNA library and use thereof to monitor differentiation |
| 06/06/2000 | US6071694 Screening method for therapeutic agents against Alzheimer's disease |
| 06/06/2000 | US6071692 Inserting exogenous genes into cells; inserting gene into plasmid and transforming cell |
| 06/06/2000 | US6071691 Screening for modulators of cell differentiation; monitoring expression levels of a marker protein in suppressed cells, monitoring expression of marker protein after incubation with modulator |
| 06/06/2000 | US6071689 System for improving yield of sexed embryos in mammals |
| 06/06/2000 | US6071522 Cloning of mite allergens |
| 06/06/2000 | US6071520 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| 06/06/2000 | US6071519 Treating autoimmune diseases, hodgkin's disease and other lymph cancers |
| 06/06/2000 | US6071518 GP900 glycoprotein and fragments for treatment and detection/diagnosis of cryptosporidium |
| 06/06/2000 | US6071512 Administering replication defective recombinant retrovirion with gene operable linked to control sequence |
| 06/06/2000 | US6071395 Process and device for isolating nucleic acids |
| 06/06/2000 | US6071394 Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis |
| 06/06/2000 | CA2210900C Method and composition for stabilization of labelled nucleoside triphosphates |
| 06/06/2000 | CA2203627C Rapid detection and identification of nucleic acid variants and pathogens |
| 06/06/2000 | CA2047683C Neuronal nicotinic acetylcholine receptor compositions containing the beta 4 subunit |
| 06/06/2000 | CA1341020C Lipoprotein i (ompi) of pseudomonas aeruginosa |
| 06/06/2000 | CA1341019C Plant elongation factor promoters, coding sequences and uses |
| 06/06/2000 | CA1341015C Outer membrane protein f of pseudomonas aeruginosa |
| 06/06/2000 | CA1341013C Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells |
| 06/06/2000 | CA1341012C Dna sequences, recombinant dna molecules and processes for producing swine growth hormone-like polypeptides |
| 06/04/2000 | CA2291356A1 Recombinant, adenoviral vector having limited autoreplication capability in vivo |
| 06/02/2000 | WO2000031547A1 Prion protein standard and method of making same |
| 06/02/2000 | WO2000031546A1 Antibodies to peptides that target git receptors and related methods |
| 06/02/2000 | WO2000031540A1 Immunostimulatory dna |
| 06/02/2000 | WO2000031537A1 Detection of biomolecules using phage reagents |
| 06/02/2000 | WO2000031517A1 Method and device for automated chromophore-assisted laser/light inactivation (cali) |
| 06/02/2000 | WO2000031306A2 Multiplex amplification of short tandem repeat loci |
| 06/02/2000 | WO2000031305A2 Primer extension methods utilizing donor and acceptor molecules for detecting nucleic acids |
| 06/02/2000 | WO2000031304A1 Methods and apparatus for flow-through hybridization |
| 06/02/2000 | WO2000031303A2 Methods for stool sample preparation |
| 06/02/2000 | WO2000031302A1 In situ binary synthesis of biologically effective molecules |
| 06/02/2000 | WO2000031299A2 Method for determining nucleotide sequences using arbitrary primers and low stringency |
| 06/02/2000 | WO2000031296A1 Antisense modulation of interleukin-15 expression |
| 06/02/2000 | WO2000031294A2 Method for identifying cytosine methylation patterns in genomic dna |
| 06/02/2000 | WO2000031289A1 Use of activated trap for screening for specific inhibitor of trap and method for aiding in the identification of a compound for use in the treatment of diseases or degenerative conditions resulting in increased bone resorption |
| 06/02/2000 | WO2000031287A1 Process for processing sucrose into glucose |
| 06/02/2000 | WO2000031286A1 Adenoviral vector-mediated delivery of modified steroid hormone receptors and related products and methods |
| 06/02/2000 | WO2000031285A1 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
| 06/02/2000 | WO2000031284A1 Protein expression vector and utilization thereof |
| 06/02/2000 | WO2000031283A2 Regulatory sequences useful for gene expression in plant embryo tissue |
| 06/02/2000 | WO2000031282A1 Genetically modified plants with altered starch |
| 06/02/2000 | WO2000031281A2 Dna sequence encoding a glutamate/malate translocator, plasmids, bacteria, yeasts and plants containing said transporter |
| 06/02/2000 | WO2000031280A2 Use of plus-strand synthesis elements in retroviral vectors |
| 06/02/2000 | WO2000031279A2 Producing antimicrobial cationic peptides as fusion proteins |
| 06/02/2000 | WO2000031278A1 Zace1: a human metalloenzyme |
| 06/02/2000 | WO2000031277A1 Novel serine proteases bssp4 |
| 06/02/2000 | WO2000031276A1 Gene coding for an alpha-agarase and use thereof for producing enzymes for the biodegradation of agars |
| 06/02/2000 | WO2000031275A1 Recombinant lysophosphatidic acid phosphatase |